AIM ImmunoTech, Inc. (AIM)
1.55
+0.03
(+1.97%)
USD |
NYAM |
Dec 09, 12:41
AIM ImmunoTech EPS Diluted (Quarterly): -1.569 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Perspective Therapeutics, Inc. | -0.3495 |
| Protalix Biotherapeutics, Inc. | 0.0291 |
| Electromed, Inc. | 0.246 |
| Xtant Medical Holdings, Inc. | 0.0087 |
| Armata Pharmaceuticals, Inc. | -0.7363 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.284M |
| Revenue (Quarterly) | 0.026M |
| Total Expenses (Quarterly) | 3.31M |
| Enterprise Value | 1.091M |
| Gross Profit Margin (Quarterly) | -369.2% |
| Profit Margin (Quarterly) | -12.63K% |
| Earnings Yield | -963.9% |
| Normalized Earnings Yield | -959.59 |